Indian citizens lack free access to essential generic medicines, while policies risk undermining new drug research funding

17 July 2013

Modern India has the third largest national economy in the world in purchasing power adjusted terms. The country is also now the world’s largest generic medicines exporter. But 400'600 million Indian citizens live in severe poverty.

Many still lack assured free access to good quality generic medicines and the support needed to use them to best effect. Unmet need is particularly high in the context of preventing and treating the growing burden of heart problems, strokes and other non'communicable diseases (NCDs) like diabetes, finds a new report from the UK’s UCL School of Pharmacy, published today (July 17).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Generics